Nolato AB

Latest Results (09.07.2026):

Nolato AB – first quarter of 2026: Nolato reported stable margins and modest currency-adjusted volume growth in Q1 2026, with consolidated sales of SEK 2,357m (2,453), EBITA of SEK 260m (271) and an unchanged EBITA margin of 11.0%. Profit after tax was SEK 181m (199), EPS SEK 0.67 (0.74). Cash flow and the balance sheet strengthened, supporting a continued acquisition agenda and capacity investments.

Sales & growth

Group sales SEK 2,357m (2,453). Exchange rates reduced reported sales by ~7%; currency-adjusted sales rose about 3% year‑on‑year. Medical Solutions SEK 1,345m, Engineered Solutions SEK 1,020m.

Profitability

Operating profit (EBITA) SEK 260m (271). EBITA margin unchanged at 11.0%. Operating profit (EBIT) SEK 250m (260). Profit after financial items SEK 232m (252).

Net income & EPS

Profit after tax SEK 181m (199). Earnings per share, basic and diluted, SEK 0.67 (0.74). Effective tax rate 22.0%.

Business-area highlights

Medical Solutions (57% of revenues): sales SEK 1,345m, +5% currency‑adjusted; EBITA SEK 159m, margin 11.8% (slightly below prior year due to start‑up costs and ramping new products). Engineered Solutions: sales SEK 1,020m, +1% currency‑adjusted; EBITA SEK 108m, margin 10.6% helped by a stronger Materials mix (Materials +15% currency‑adjusted).

Cash flow & investments

Cash flow from operating activities improved to SEK 225m (135). Net investments (excl. acquisitions/disposals) SEK 193m (271), leaving cash flow after investments SEK 32m (-136).

Financial position

Net financial liabilities SEK 737m (757). Net financial liabilities / adjusted EBITDA 0.5x. Equity/assets ratio 60%. Interest-bearing assets SEK 452m; leverage and liquidity judged strong enough to support planned acquisitions.

Operational items & outlook

Average employees 5,607 (5,405); capacity expansions underway in Hungary and Poland and new operations being established in Malaysia. CEO: resilient operations despite geopolitical uncertainty; focus on innovation, efficiency and supply‑chain actions. No significant events after the reporting date.